首页
订购/客服:400-666-5481

M435-1279

    
98.50%

M435-1279

源叶(MedMol)
S89332 一键复制产品信息
1359431-16-5
C18H17N3O5S2
419.47
货号 规格 价格 上海 北京 珠海 重庆 武汉 购买数量
S89332-5mg买3赠1
98.50%

¥450.00

5 - - - -
S89332-10mg买3赠1
98.50%

¥600.00

7 - - - -
S89332-25mg
98.50%

¥850.00

4 - - - -
S89332-100mg
≥98%

¥2480.00

货期:2-3天 - - - -
产品介绍 参考文献 质检证书(COA) 摩尔浓度计算器 相关产品
产品描述: M435-1279 is a UBE2T inhibitor. M435-1279 blocks UBE2T-mediated degradation of RACK1, leading to inhibit the hyperactivation of Wnt/β-catenin signaling pathway
靶点: E1/E2/E3 Enzyme;E1/E2/E3Enzyme
体外研究: M435-1279 (0, 2, 4, 8, 16, 31 μM; 48 h) significantly inhibits the growth of HGC27, AGS, and MKN45 cells.
M435-1279 (0, 4, 8, 12, 16, 20 μM) inhibits the cell viability with IC50s of 16.8, 11.88, 6.93, 7.76 μM of GES-1, HGC27, MKN45, AGS cells, respectively.
M435-1279 (31 nM to 500 μM) binding to UBE2T with a KD value of 50.5 μM.
M435-1279 (11.88 μM; 48 h) inhibits the ubiquitination of RACK1 and the hyperactivation of the Wnt/β-catenin pathway.
体内研究: M435-1279 (5 mg/kg/day; intratumor injection for 18 days) slows the tumor growth. M435-1279 induces higher RACK1 proteins expression, and lower Ki-67 and β-catenin proteins expression in intratumor tumors.
参考文献: 1. Yu Z, et al. A novel UBE2T inhibitor suppresses Wnt/β-catenin signaling hyperactivation and gastric cancer progression by blocking RACK1 ubiquitination. Oncogene. 2021 Feb;40(5):1027-1042. doi: 10.1038/s41388-020-01572-w. Epub 2020 Dec 15. Erratum in: Oncogene. 2021 Apr;40(14):2622-2623.
溶解性: Soluble  in  DMSO
保存条件: -20℃
配置溶液浓度参考:
1mg 5mg 10mg
1 mM 2.384 ml 11.92 ml 23.84 ml
5 mM 0.477 ml 2.384 ml 4.768 ml
10 mM 0.238 ml 1.192 ml 2.384 ml
50 mM 0.048 ml 0.238 ml 0.477 ml
注意: 部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。

参考文献

质检证书(COA)

如何获取质检证书(COA)?
请输入货号和一个与之匹配的批号。
例如:
批号:JS298415 货号:S20001-25g
在货品标签上如何找到货号和批号?

摩尔浓度计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)

=
×
×